13th Asian & Oceanian Epilepsy Congress10-13 June 2021 | Virtual Congress
Friday 11 June; 17:30-18:30 JST
Hall 1: Fukuoka
Eisai: Patient’s reality during COVID-19: treatment strategy considering comorbid conditions
Chair: Kiyohito TERADA (Japan)
Speaker: Manuel TOLEDO (Spain)
Live Q&A with the Panel
Hall 2: Tokyo
UCB: The value of sodium channel blockers for IGE with GTCS: new evidence for Vimpat® (lacosamide)
Speaker: Terry O’BRIEN (Australia)
Speaker: Philippe RYVLIN (France)
Speaker: Hideaki SHIRAISHI (Japan)
Saturday 12 June; 17:30-18:30 JST
Eisai: Precision medicine: AMPA biology from basic science to clinical practice
Chair: Naoki AKAMATSU (Japan)
Pathogenesis and treatment progress of post-stroke epilepsy: role of Glutamate AMPA receptor
Speaker: Qun WANG (China)
Age-related etiology, treatment, and Glutamate-AMPA relationship between epilepsy and dementia Speaker: William Chin Wei HUANG (Taiwan)
UCB: Epilepsy and pregnancy: balancing opportunities and challenges
Chair: Torbjörn TOMSON (Sweden)
Co-chair: Xiaoqui SHAO (China)
Speaker: Hideyuki OHTANI (Japan)
Speaker: Sanjeev THOMAS (India)
Saturday 12 June; 17:30-18:30
Hall 3: Tokyo
BioMarin: Differential diagnosis and treatment for early-onset pediatric epilepsies
Speaker: Andreas HAHN (Germany)
Friday 11 June; 09:30-09:45 JST
UCB: The relevance of mood and psychiatric symptoms for the selection of anti-seizure medications
Speaker: Bettina SCHMITZ (Germany)
Saturday 12 June; 09:30-09:45 JST
UCB: Advancing treatment in PGTCS: adjunctive VIMPAT® (lacosamide) in patients (≥4 years of age) with IGE in a novel time to event trial
Speaker: Jacqueline FRENCH (USA)
Live Q&A
Sunday 13 June; 09:30-09:45 JST
UCB: Physician burnout: an unmet need
Speaker: Raman SAGGU (Germany)